期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

IL-6与宫颈癌 被引量：1

下载PDF
导出
摘要 宫颈癌是最常见的妇科恶性肿瘤,它的恶性进展伴随着细胞生长的不平衡、浸润和转移、生物学特性的获得和逃避免疫监视。在宫颈癌患者的体液、癌组织中都有IL-6的表达,在调节细胞的生长、凋亡、转移和对局部、全身的免疫调节都起到重要的作用。而功能上的多效性及复杂性是由它的受体系统决定的。现对IL-6在宫颈组织发生癌变过程中的作用做一综述。
作者 刘艳波 蔡莲莲
机构地区 温州医学院附属第二医院妇产科
出处 《国外医学（计划生育分册）》 2004年第3期164-168,共5页
关键词 IL-6 宫颈癌 恶性肿瘤 妇科 细胞生长 血管生成
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Sugiyama T. Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis. J Bone Miner Metab, 2001,19(2):89-96.
  • 2Montero-Julian FA. The soluble IL-6 receptors: serum levels and biological function. Cell Mol Biol (Noisy-le-grand), 2001, 47(4):583-597.
  • 3Xuan YT, Guo Y, Han H, et al. An essential role of the Jak-Stat Pahway in ischemic preconditioning. Proc Natl Acad Sci U S A, 2001,98( 16):9050-9055.
  • 4Januma N, Shima H, Nakamura K, et al. Protein tyrosine phsphatase epsilon c selectively inhibits interleukin-6 and il-6 induced Jak-Stat signaling. Blood, 2001, 98(10):3030-3034.
  • 5Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signaling. Nature, 1997, 387:917-921.
  • 6Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res, 2002, 4[Suppl 3]:S233-242.
  • 7Wei LH, Kuo ML, Chen CA, et al. Interleukin-6 in cervical cancer:the relationship with vascular endothelial growth factor. Gynecol Oncol, 2001, 82(1):49-56.
  • 8Srivani R, Nagarajan B. A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer, 2003,13(3): 331-339.
  • 9Wei LH, Kuo ML, Chen CA, et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene, 2003, 22(10): 1517-1527.
  • 10Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene,2002, 21 (13):2000-2008.

同被引文献13

  • 1张越林,邱曙东,刘瑄,党小军.脑胶质细胞瘤患者IL-6的表达及细胞免疫功能的变化[J].西安交通大学学报（医学版）,2004,25(6):581-583. 被引量：2
  • 2刘艳波,蔡莲莲,王宗敏,赵志光.白细胞介素6在子宫颈癌组织中的表达及其与血管生成的关系[J].中华妇产科杂志,2005,40(3):197-199. 被引量：11
  • 3Tartour E,Gey A,Sastre-Garau X,et al.Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay:evidence for enhanced interleukin 6 gene expression in invasive carcinoma[J].Cancer Res,1994,54(23):6243-6248.
  • 4Crawford RAF,Caldwell C,Iles RK,et al.Prognostic significance of the Bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer[J].Br Cancer,1998,78:210-214.
  • 5Kawano M,Hirano T,Matsuda T,et al.Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas[J].Nature,1988,332:83-85.
  • 6Nakashima K,Wiese S,Yanagisawa M,et al.Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation[J].J Neurosci,1999,19(13):5429-5434.
  • 7Wei LH,Kuo ML,Chen CA,et al.Interleukin-6 in cervical cancer:The relationship with vascular endothelial growth factor[J].Gynecologic Oncology,2001,82(1):49-56.
  • 8Wei LH,Kuo ML,Chen CA,et al.Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway[J].Oncogene,2003,22:1517-1527.
  • 9Wei LH,Kuo ML,Chen CA,et al.The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of MCL-1 through a PI3-K/Akt pathway[J].Oncogene,2001,20:5799-5809.
  • 10Krajewski S,Bodrug S,Krajewska M,et al.Immunohistochemical analysis of MCL-1 protein in human tissues[J].Am J Pathol,1995,146(6):1309-1319.

引证文献1

国外医学（计划生育分册）
2004年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部